Literature DB >> 15090706

Repeated sauna therapy reduces urinary 8-epi-prostaglandin F(2alpha).

Akinori Masuda1, Masaaki Miyata, Takashi Kihara, Shinichi Minagoe, Chuwa Tei.   

Abstract

We have reported that repeated sauna therapy improves impaired vascular endothelial function in a patient with coronary risk factors. We hypothesized that sauna therapy decreases urinary 8-epi-prostaglandin F(2alpha) (PGF(2alpha)) levels as a marker of oxidative stress and conducted a randomized, controlled study. Twenty-eight patients with at least one coronary risk factor were divided into a sauna group (n = 14) and non-sauna group (n = 14). Sauna therapy was performed with a 60 degrees C far infrared-ray dry sauna for 15 minutes and then bed rest with a blanket for 30 minutes once a day for two weeks. Systolic blood pressure and increased urinary 8-epi-PGF(2alpha) levels in the sauna group were significantly lower than those in the non-sauna group at two weeks after admission (110 +/- 15 mmHg vs 122 +/- 13 mmHg, P < 0.05, 230 +/- 67 pg/mg x creatinine vs 380 +/- 101 pg/mg x creatinine, P < 0.0001, respectively). These results suggest that repeated sauna therapy may protect against oxidative stress, which leads to the prevention of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090706     DOI: 10.1536/jhj.45.297

Source DB:  PubMed          Journal:  Jpn Heart J        ISSN: 0021-4868


  16 in total

Review 1.  Far-infrared saunas for treatment of cardiovascular risk factors: summary of published evidence.

Authors:  Richard Beever
Journal:  Can Fam Physician       Date:  2009-07       Impact factor: 3.275

Review 2.  Far-infrared therapy for cardiovascular, autoimmune, and other chronic health problems: A systematic review.

Authors:  Shanshan Shui; Xia Wang; John Y Chiang; Lei Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2015-02-25

Review 3.  Effect of heat stress on vascular outcomes in humans.

Authors:  Jem L Cheng; Maureen J MacDonald
Journal:  J Appl Physiol (1985)       Date:  2019-01-24

4.  Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1.

Authors:  Chih-Ching Lin; Xiao-Ming Liu; Kelly Peyton; Hong Wang; Wu-Chang Yang; Shing-Jong Lin; William Durante
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-17       Impact factor: 8.311

Review 5.  Novel therapies for hemodialysis vascular access dysfunction: myth or reality?

Authors:  Christi M Terry; Laura M Dember
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 8.237

6.  Thermotherapy reduces blood pressure and circulating endothelin-1 concentration and enhances leg blood flow in patients with symptomatic peripheral artery disease.

Authors:  Dustin Neff; Alisha M Kuhlenhoelter; Chen Lin; Brett J Wong; Raghu L Motaganahalli; Bruno T Roseguini
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-06-22       Impact factor: 3.619

Review 7.  Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies.

Authors:  Setor K Kunutsor; Samuel Seidu; Kamlesh Khunti
Journal:  Eur Heart J       Date:  2017-05-21       Impact factor: 29.983

8.  The skin function: a factor of anti-metabolic syndrome.

Authors:  Shi-Sheng Zhou; Da Li; Yi-Ming Zhou; Ji-Min Cao
Journal:  Diabetol Metab Syndr       Date:  2012-04-26       Impact factor: 3.320

9.  Effects of far infrared light on Alzheimer's disease-transgenic mice.

Authors:  Koji Fukui; Shunsuke Kimura; Yugo Kato; Masahiro Kohno
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

10.  Clinical utility of far-infrared therapy for improvement of vascular access blood flow and pain control in hemodialysis patients.

Authors:  Soo Jeong Choi; Eun Hee Cho; Hye Min Jo; Changwook Min; Young Sok Ji; Moo Yong Park; Jin Kuk Kim; Seung Duk Hwang
Journal:  Kidney Res Clin Pract       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.